Colorectal Surgery (Proctology) — Medicare Part B billing by state
60 physician groups whose primary specialty is Colorectal Surgery (Proctology) billed $33.3M to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Minnesota | $19.8M | $19.8M | 1 | $19.8M | 1.1M | 71,867 | 1.1M |
| Pennsylvania | $4.0M | $4.0M | 5 | $806K | 14,029 | 8,092 | 2,806 |
| New York | $1.8M | $1.9M | 8 | $243K | 13,480 | 10,199 | 1,685 |
| North Carolina | $853K | $733K | 2 | $367K | 3,373 | 2,375 | 1,686 |
| California | $823K | $912K | 8 | $114K | 10,822 | 6,188 | 1,353 |
| Massachusetts | $601K | $612K | 3 | $204K | 8,190 | 4,129 | 2,730 |
| Arizona | $581K | $548K | 4 | $137K | 5,208 | 4,363 | 1,302 |
| Kentucky | $538K | $513K | 1 | $513K | 6,183 | 4,984 | 6,183 |
| Virginia | $503K | $505K | 2 | $252K | 4,276 | 3,970 | 2,138 |
| Maryland | $474K | $514K | 4 | $128K | 3,972 | 3,236 | 993 |
| Alabama | $460K | $407K | 3 | $136K | 3,356 | 3,085 | 1,119 |
| New Jersey | $394K | $420K | 3 | $140K | 4,278 | 3,028 | 1,426 |
| Florida | $330K | $333K | 4 | $83K | 4,204 | 2,875 | 1,051 |
| Texas | $295K | $288K | 3 | $96K | 5,563 | 3,582 | 1,854 |
| Illinois | $293K | $308K | 3 | $103K | 3,078 | 2,331 | 1,026 |
| Georgia | $290K | $291K | 3 | $97K | 2,458 | 2,056 | 819 |
| Indiana | $252K | $242K | 2 | $121K | 2,076 | 1,866 | 1,038 |
| Michigan | $160K | $170K | 2 | $85K | 1,764 | 1,297 | 882 |
| South Carolina | $159K | $157K | 1 | $157K | 1,566 | 1,524 | 1,566 |
| Tennessee | $97K | $87K | 1 | $87K | 1,094 | 934 | 1,094 |
| Kansas | $96K | $91K | 1 | $91K | 1,080 | 734 | 1,080 |
| Hawaii | $96K | $97K | 1 | $97K | 759 | 718 | 759 |
| Nevada | $70K | $67K | 1 | $67K | 620 | 522 | 620 |
| Alaska | $62K | $78K | 1 | $78K | 736 | 636 | 736 |
| Oregon | $58K | $60K | 1 | $60K | 543 | 510 | 543 |
| Connecticut | $34K | $36K | 2 | $18K | 353 | 309 | 176 |
| Missouri | $32K | $31K | 1 | $31K | 264 | 255 | 264 |
| Washington | $10K | $10K | 1 | $10K | 110 | 99 | 110 |
| Wisconsin | $2K | $2K | 1 | $2K | 25 | 24 | 25 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
5 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $7.6M | 172K | MNPANYNCCA |
| Q4271 · Complete ft, per square centimeter | $2.8M | 2,116 | MNPANYNCCA |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | $1.2M | 30,780 | MNPANYNCCA |
| J9299 · Injection, nivolumab, 1 mg | $800K | 32,580 | MNPANYNCCA |
| J9043 · Injection, cabazitaxel, 1 mg | $735K | 4,380 | MNPANYNCCA |
| J0185 · Injection, aprepitant, 1 mg top by services | $291K | 217K | MNPANYNCCA |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | $284K | 123K | MNPANYNCCA |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | $28K | 103K | MNPANYNCCA |
| J9171 · Injection, docetaxel, 1 mg top by services | $27K | 39,059 | MNPANYNCCA |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | $3K | 34,887 | MNPANYNCCA |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $3K | 29,238 | MNPANYNCCA |
| J9267 · Injection, paclitaxel, 1 mg top by services | $2K | 31,756 | MNPANYNCCA |